ICLR News and Press, ICON plc From 02/22/22

Icon press release (NASDAQ:ICLR): Q4 GAAP EPS of $2.63 beats by $1.01. Revenue of $1.89B (+148.6% Y/Y) misses by $10M. Adjusted revenue of $1,881.1 million representing a year on year increase of 147.4%.  Adjusted EBITDA  was $332.5M or 17.7% of revenue, a year on year increase of 1...

Highlights Record net business wins in the quarter of $2,378 million; a net book to bill of 1.26. Full year net business wins of $6,958 million; a net book to bill of 1.27. Closing backlog of $19.1 billion, an increase of 2.6% on Q3 2021 or an increase of 9.5% year over ye...

ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Citi Healthcare Conference on Thursday, February 24, 2022 at 11:45am ET. Any changes t...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A focus on de-risking investments prior to purchase and m...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance was driven by our U.S. exposure, ...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance was driven by diversified contrib...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance in the quarter and the year was d...

Highlights Full Year 2022 Revenue guidance in the range of $7,770 - $8,050 million, representing growth of 43 – 46% over Full Year 2021 Revenue guidance. Full Year 2022 adjusted earnings per share guidance in the range of $11.55 - $11.95, representing growth of 21 &...

ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 40 th Annual JP Morgan Healthcare Conference on Wednesday, January 12, 2022 at 07.30am ET. ...

Avantor is a fascinating way to play the broader science industry due to its vast portfolio of offerings. Recent performance by Avantor has been appealing, with revenue and cash flows rising while losses turn to profits. AVTR stock is pricey but relative to the growth the company ...